≡

ELISA Kit for Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS)

CMT2D; CMT2-D; DSMAV; GlyRS; SMAD1; EJ; Charcot-Marie-Tooth Neuropathy 2D; Glycine tRNA Ligase; Diadenosine tetraphosphate synthetase; AP-4-A synthetase

Specificity

This assay has high sensitivity and excellent specificity for detection of Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS).
No significant cross-reactivity or interference between Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-98 94
EDTA plasma(n=5) 85-103 89
heparin plasma(n=5) 82-92 87

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-99% 80-101% 87-102% 88-96%
EDTA plasma(n=5) 83-91% 92-99% 82-91% 83-97%
heparin plasma(n=5) 78-97% 84-104% 90-98% 87-95%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 5 times;
5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
6. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Oncotarget Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme 33473259
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC996Hu01 Recombinant Glycyl tRNA Synthetase (GARS) Positive Control; Immunogen; SDS-PAGE; WB.
PAC996Hu01 Polyclonal Antibody to Glycyl tRNA Synthetase (GARS) WB; IHC; ICC/IF; FCM
MAC996Hu22 Monoclonal Antibody to Glycyl tRNA Synthetase (GARS) WB; IHC; ICC; IP.
SEC996Hu ELISA Kit for Glycyl tRNA Synthetase (GARS) Enzyme-linked immunosorbent assay for Antigen Detection.
AEC996Hu ELISA Kit for Anti-Glycyl tRNA Synthetase Antibody (Anti-GARS) Enzyme-linked immunosorbent assay for Antibody Detection.
LMC996Hu Multiplex Assay Kit for Glycyl tRNA Synthetase (GARS) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.